Nkarta Inc
NASDAQ:NKTX

Watchlist Manager
Nkarta Inc Logo
Nkarta Inc
NASDAQ:NKTX
Watchlist
Price: 2.42 USD 2.98% Market Closed
Market Cap: 170.8m USD
Have any thoughts about
Nkarta Inc?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of NKTX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NKTX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-4.5
Industry
22.1
Forward
-1.4
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-6.1
Industry
21.9
vs History
vs Industry
Median 3Y
-3.9
Median 5Y
-5.1
Industry
23.4
vs History
81
vs Industry
62
Median 3Y
1
Median 5Y
1.4
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.3
vs History
18
vs Industry
21
Median 3Y
-0.6
Median 5Y
-2
Industry
4.2
Forward
0.9
vs History
18
vs Industry
20
Median 3Y
-0.6
Median 5Y
-1.9
Industry
4
Forward
0.8
vs History
22
vs Industry
23
Median 3Y
-0.7
Median 5Y
-2.7
Industry
5.9
vs History
18
vs Industry
20
Median 3Y
-0.7
Median 5Y
-2.4
Industry
3.9
vs History
vs Industry
72
Median 3Y
0.4
Median 5Y
2.2
Industry
4.5

Multiples Across Competitors

NKTX Competitors Multiples
Nkarta Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Nkarta Inc
NASDAQ:NKTX
170.8m USD 0 -1.5 0.9 0.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 059 457.3 -180 891 -219 659.2 -217 152.6
US
Abbvie Inc
NYSE:ABBV
316.7B USD 5.7 62.3 15.5 23.8
US
Amgen Inc
NASDAQ:AMGN
141.5B USD 4.3 33.4 16 30.4
US
Gilead Sciences Inc
NASDAQ:GILD
117.6B USD 4.2 933.6 10.4 10.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.8B USD 10 -220.6 21.8 22.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 851 -472.3 -514.4 -500.7
AU
CSL Ltd
ASX:CSL
136.4B AUD 5.7 32.1 19.9 24.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD 5.7 17 15.4 17.1
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.7 -53
NL
argenx SE
XBRU:ARGX
36.2B EUR 19.4 -136.1 -109.9 -80.1
P/S Multiple
Revenue Growth P/S to Growth
US
Nkarta Inc
NASDAQ:NKTX
Average P/S: 3 806 138.1
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
38 059 457.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.3
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.2
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
34%
0.3
US
E
Epizyme Inc
F:EPE
1 851
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.4
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
US
Nkarta Inc
NASDAQ:NKTX
Average P/E: 215.7
Negative Multiple: -1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 891 N/A N/A
US
Abbvie Inc
NYSE:ABBV
62.3
413%
0.2
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
933.6
77%
12.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -220.6
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.3 N/A N/A
AU
CSL Ltd
ASX:CSL
32.1
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.1 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Nkarta Inc
NASDAQ:NKTX
Average EV/EBITDA: 14.3
0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 659.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.8
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.4 N/A N/A
AU
CSL Ltd
ASX:CSL
19.9
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Nkarta Inc
NASDAQ:NKTX
Average EV/EBIT: 18.6
0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 152.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.8
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.4
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.7 N/A N/A
AU
CSL Ltd
ASX:CSL
24.8
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -80.1 N/A N/A

See Also

Discover More
Back to Top